Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,269 public trials 1,194 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

Berzosertib + Topotecan in Relapsed Platinum-Resistant Small-Cell Lung Cancer (DDRiver SCLC 250)

NCT04768296

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Congenital Abnormalities, +19 more
Locations
  • Providence Medical Foundation Santa Rosa, California, United States
  • St Joseph Heritage Healthcare Santa Rosa, California, United States
  • Cotton-O'Neil Clinical Research Center, Hematology and Oncology Topeka, Kansas, United States
  • National Cancer Institute Bethesda, Maryland, United States
View all 51 locations
View Trial Details
Completed

A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China

NCT03565003

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +40 more
Locations
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Chinese PLA Central Hospital Beijing, Beijing Municipality, China
View Trial Details
Completed

Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer

NCT00365105

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +30 more
Locations
  • Providence Cancer Center at Providence Hospital Mobile, Alabama, United States
  • Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center Burbank, California, United States
  • Mercy Cancer Center at Mercy San Juan Medical Center Carmichael, California, United States
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
View all 147 locations
View Trial Details
Completed

A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)

NCT02927301

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCLA Cancer Center Santa Monica, California, United States
  • University Of Colorado Aurora, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 19 locations
View Trial Details

Related conditions